Medicare limits coverage Aduhelm, the $28,000-a-year Alzheimer's drug from Biogen
Published
Aduhelm's initial yearly price of $56,000 led to the largest-ever increase, in dollars, for Medicare's monthly "Part B" premium for outpatient care.
Published
Aduhelm's initial yearly price of $56,000 led to the largest-ever increase, in dollars, for Medicare's monthly "Part B" premium for outpatient care.
Shares of Biogen Inc (NASDAQ: BIIB) are down about 8.0% on Wednesday after the U.S. Medicare programme refused to cover for its..
WASHINGTON (AP) — U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing..